Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 23, 2017 ) The Europe market for nuclear medicine Radiopharmaceuticals Industry is estimated at $1.04 Billion in 2015 and is expected to reach $1.78 billion by 2020, growing at a CAGR of 11.4%. Nuclear medicine falls under the field of Molecular imaging, which involves usage of minute amount of radioactive material (radiopharmaceuticals) to diagnose and treat disease. View Full Report @ http://www.marketdataforecast.com/market-reports/europe-nuclear-medicine-radiopharmaceuticals-market-131/ Increasing prevalence of chronic diseases such as cancer and cardiac ailments, rapid technological advancements, increasing demand for SPECT and PET applications and the growing public awareness for healthcare are fuelling the market growth for Radiopharmaceuticals. Further, Integration of X ray tomography (CT) into SPECT has emerged as an excellent diagnostic tool in the medical imaging and is considered to be a driving factor for the growth of the market. Strict regulatory framework pose as a great hurdle to translational research & clinical investigations and reimbursement issues are blocking the growth of the market. In addition, shorter half-life of radiopharmaceuticals and competition from orthodox diagnostic procedures are the key factors restraining the Europe nuclear medicine Radioisotopes market. Download Free Sample Report @ http://www.marketdataforecast.com/market-reports/europe-nuclear-medicine-radiopharmaceuticals-market-131/request-sample Market Segmentation • By Type o Diagnostic Radioisotopes o SPECT Technetium-99m Thallium-201 Gallium-67 Iodine-23 Others o PET Fluorine-18 Rubidium-82 Others • Therapeutic Radioisotopes o Beta Emitters Iodine-131 Yttrium-90 Samarium-153 Rhenium-186 Lutetium-177 Alpha Emitters • Radium-223 o Brachytherapy o Cesium-131 o Iodine-125 o Palladium-103 o Iridium-192 • By Application o Cardiology o Lymphoma o Thyroid o Neurology o Oncology o Others Avail Discount @ http://www.marketdataforecast.com/market-reports/europe-nuclear-medicine-radiopharmaceuticals-market-131/request-discount Radiopharmaceuticals market is dominated by diagnostic radioisotopes with a market share of 90 % while therapeutic radioisotopes contribute a minor share of around 10% of the market. Based on type of radioisotopes the market is segmented into Technetium-99m (TC-99m), Thallium-201 (TL-201), Fluorine-18,Iodine (I-123), Rubidium-82 (RB-82) and others. The F-18 market is mostly contributed by F-18 FDG tracers though this market is enriched with future tracers such as F-18 Florbetapir and F-18 Choline. The promising clinical outcomes of these tracers have been gaining the business interest of major research institutes and PET isotope players. Ga-68 and Rb-82 are two new potential isotopes in the PET diagnostic market, ensuring high growth of the diagnostics segment. Diagnosis of coronary artery disease, bone metastasis, and Alzheimer’s disease are the most promising indications for the future PET radioisotopes market. Buy now @ https://www.marketdataforecast.com/cart/buy-now/europe-nuclear-medicine-radiopharmaceuticals-market-131 Some of the key players influencing the Europe nuclear medicine market are GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation,Positron Corporation,Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and IBA Molecular Imaging. About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|